fri lavie 825 - baptist health south floridalavie cj et al. nat.rev.endocrinol 2015;11:55-62...

15
2/11/2017 1 Weighing the “Heavy” Cardiovascular Burden of Obesity and the “Obesity Paradox” Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology Director, Exercise Laboratories John Ochsner Heart and Vascular Institute Ochsner Clinical School-The UQ School of Medicine New Orleans, La Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology Director, Exercise Laboratories John Ochsner Heart and Vascular Institute Ochsner Clinical School-The UQ School of Medicine New Orleans, La Disclosures Consultant for Mio Global for their Personalized Activity Intelligence (PAI) applications based on our Am J Med PAI paper published on-line October 2016; Also, he is the author of The Obesity Paradox Lavie CJ et al. J Am Coll Cardiol 2009; 53:1925-32.

Upload: others

Post on 15-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

1

Weighing the “Heavy” Cardiovascular Burden of Obesity

and the “Obesity Paradox”

Carl J. Lavie, MD, FACC, FACP, FCCP

Professor of Medicine

Medical Director, Cardiac Rehabilitation and

Preventive Cardiology

Director, Exercise Laboratories

John Ochsner Heart and Vascular Institute

Ochsner Clinical School-The UQ School of Medicine

New Orleans, La

Carl J. Lavie, MD, FACC, FACP, FCCP

Professor of Medicine

Medical Director, Cardiac Rehabilitation and

Preventive Cardiology

Director, Exercise Laboratories

John Ochsner Heart and Vascular Institute

Ochsner Clinical School-The UQ School of Medicine

New Orleans, La

Disclosures

Consultant for Mio Global for their Personalized Activity

Intelligence (PAI) applications based on our Am J Med PAI

paper published on-line October 2016;

Also, he is the author of The Obesity Paradox

Lavie CJ et al. J Am Coll Cardiol 2009; 53:1925-32.

Page 2: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

2

PCD

Obesity and O

besity Paradox in Cardiovascular

Diseases

Vol. 56, N

o. 4—January/February 2014 (pp

367–472)

Elsevier

Progress inCardiovascularDiseases

Vol . 56, No. 4January/February

2014

www.onlinepcd.com

2012Impact Factor

4.000

Obesity and Obesity Paradoxin Cardiovascular Diseases

Carl J. Lavie, MDEditor-in-Chief

Christopher J. White, MDand Hector O. Ventura, MD

Editors

Obesity and Cardiovascular Diseases

• Obesity increasing in epidemic proportions

• Body mass index (BMI) is primarily used

• Body fatness, waist circumference (WC), waist to hip ratio (WHR), and waist to height ratio may be superior

Lavie CJ et al. JACC 2009;53:1925-1932

Obesity and Cardiovascular Diseases

• 70% of adults in US are overweight or obese

• Morbid obesity especially increased

• Obesity is second to only tobacco abuse as the #1 cause of preventable death in US

• Due to obesity, we may soon see a reversal in the steady increase in life expectancy

Lavie CJ et al. JACC 2009;53:1925-1932

Page 3: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

3

Adverse Effects of ObesityAdverse Effects of Obesity

• Increases in insulin resistanceGlucose intoleranceMetabolic SyndromeType 2 Diabetes Mellitus

• Hypertension• Abnormal LV Geometry

Concentric RemodelingLVH

• Increases in insulin resistanceGlucose intoleranceMetabolic SyndromeType 2 Diabetes Mellitus

• Hypertension• Abnormal LV Geometry

Concentric RemodelingLVH

Lavie CJ et al. JACC 2009;53:1925-1932Lavie CJ et al. JACC 2009;53:1925-1932

Adverse Effects of ObesityAdverse Effects of Obesity

DYSLIPIDEMIA– Elevated total cholesterol– Elevated VLDL and triglycerides– Elevated LDL and small, dense particles– Elevated non-HDL– Elevated apolipoprotein B– Reduced HDL and apolipoprotein A-1

DYSLIPIDEMIA– Elevated total cholesterol– Elevated VLDL and triglycerides– Elevated LDL and small, dense particles– Elevated non-HDL– Elevated apolipoprotein B– Reduced HDL and apolipoprotein A-1

Lavie CJ et al. JACC 2009;53:1925-1932Lavie CJ et al. JACC 2009;53:1925-1932

Adverse Effects of Obesity

• Abnormal endothelial function• Abnormal systolic and diastolic LV function• Increased systemic inflammation (eg CRP)• Increased Pro-thrombotic state• Albuminuria• Obstructive sleep apnea / sleep disordered

breathing

Lavie CJ et al. JACC 2009;53:1925-1932

Page 4: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

4

Cardiovascular Diseases Associated With Obesity

• Hypertension• Heart Failure• Coronary Heart Disease• Atrial Fibrillation• Complex Ventricular Dysrhythmias• Stroke• Venous Thromboembolism• OSA / SDB

Lavie CJ et al. JACC 2009;53:1925-1932

Lavie CJ et al. JACC HF 2013; 1:93-102.

Obesity and Cardiovascular Disease

“Obesity Paradox” and Cardiovascular Diseases

Although obesity has been implicated as one of the major risk factors for most CV diseases, including HTN, HF, and CHD, evidence from clinical cohorts of patients with established CV diseases indicates an “obesity paradox” because overweight and obese with these diseases tend to have a more favorable short-and long-term prognosis.

Lavie CJ et al. JACC 2009;53:1925-1932

Page 5: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

5

Obesity and Hypertension

• Obesity increases levels of BP• Obesity increases CR and LVH,

independent of BP• Obesity increases metabolic

abnormalities in HTN• Despite the increased prevalence,

obese hypertensives have a favorable prognosis

Lavie CJ et al. JACC 2009;53:1925-1932

“Obesity Paradox” and Hypertension

In aggregate, although obesity is a powerful risk factor for hypertension and LVH, obese hypertensive patients may paradoxically have a better prognosis, possibly due to low SVR and PRA

Lavie CJ et al. JACC 2009;53:1925-1932

Page 6: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

6

Lavie CL et al. JACC, HF 2013:1:93-102.

Page 7: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

7

Meta-Analysis of 9 Observational StudiesOreopoulos et al. Am Heart J 2008.

The message from >28,000 CHF patients: Once you have heart failure, bigger = live longer

Obesity Status and Heart Failure Mortality

Possible Reasons for Obesity Paradox in Heart Failure

• Advanced HF is catabolic state; obese may have more metabolic reserve

• Adipose tissue produces TNF-α receptors that may neutralize TNF-α

• Obese have lower ANP and PRA• Obese have higher BP, so may tolerate more

meds• Higher circulating lipoproteins may detoxify

lipopolysaccharides that effect inflammatory cytokines

Lavie CJ et al. JACC 2009;53:1925-1932

Page 8: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

8

Obesity and CHD

• Obesity adversely effects most major CV risk factors (HTN, dyslipidemia, MetS/T2DM)

• Obesity probably an independent CHD risk factor

• Obesity strongly related with 1st

premature MI at young age (Mandala MC et al. JACC 2008;52:979-985)

Lavie CJ et al. JACC 2009;53:1925-1932

Obesity Paradox and CHD

• 40 cohort studies of over 250,000 CHD patients followed for 3.8 years

• Overweight and obese had lower risk of total and CV mortality compared with underweight and “normal” weight patients

• Similar in stable CHD, PCI and CABG

• In BMI ≥ 35 kg/m2, there was excess risk of CV mortality without an increase on total mortality

Romero-Corral A, et al. Lancet 2006; 368:666-678

Lavie CJ et al. Mayo Clin Proc 2011;86(9):857-864.

Page 9: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

9

Lavie CJ et al. Mayo Clinic Proc 2011;86(9): 857-864

The "Obesity Paradox" in CHD

Lavie CJ et al . JACC 2012;60: 1374-1380.

Lavie CJ et al. JACC 2012;60: 1374-1380

Lean Mass Index and CHD MortalityLean Mass Index and CHD Mortality

Page 10: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

10

Lavie CJ et al. JACC 2012; 60: 1374-1380

Body Fat, Lean Mass Index and CHD Mortality

Body Fat, Lean Mass Index and CHD Mortality

Lavie CJ et al. JACC 2014;63:1345-1354

Fitness vs Fatness and All-Cause Mortality

A Meta-Analysis

• Evaluated 10 studies that were prospective and objectively measured CRF and BMI and jointly assessed their impact on all-cause mortality

• Compared with NWF,Un-Fit had twice the all-cause mortality regardless of BMI

• OWF and ObF had similar survival as NWF• Fitness was more important than Fatness for long-

term mortalityBarry VW et al. Prog Cardiovasc Dis 2014;56:382-390

Page 11: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

11

McAuley PA et al. Mayo Clin Proc 2012;87(5):483-451

McAuley PA et al.Mayo Clin Proc 2012;87(5):483-451

BMI Waist Circumference

% Body Fat

Impact of Fitness on All-Cause Mortality in CHD

McAuley PA et al. Mayo Clin Proc 2012;87(5):483-451

Impact of Fitness on CVD Mortality in CHD

BMI Waist Circumference

% Body Fat

Page 12: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

12

Lavie CL et al. Mayo Clin Proc 2013; 88(3):251-258.

Fitness, Mortality, Obesity Paradox in Heart Failur e

Low Fitness Higher Fitness

Lavie CJ et al. Mayo Clin Proc 2013;88(3): 251-258

Lavie CJ et al . Am Heart J 2013

Childers DK,Allison DB.Int J Obes 2010;34:1231-1238

BMI, Survival and Age

20 yo30 yo.40 yo

50 yo

60 yo

70 yo

Page 13: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

13

Lavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014)

Obesity and Atrial Fibrillation

• As with obesity, AF is also epidemic, and is expected to increase by 2.5-fold by 2050

• May be due to HTN, CHD, and HF

• Obesity appears to be a significant AF risk factor

• In a meta-analysis of 16 studies of 125,000 subjects, obesity increased the risk of AF by 49% (Wanahita N, Messerli FH et al. Am Heart J 2008;155: 310-315.)

Lavie CJ et al. JACC 2009;53:1925-1932

Obesity Paradox in Atrial Fibrillation

Badheka AO et al. Am J Med 2010;123:646-651 .

ARRIRM Study (n=4,060)

Page 14: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

14

Badheka AO et al. Am J Med 2010;123:646-651 .

ARRIRM Study (n=4,060)

Obesity Paradox in Atrial Fibrillation

Badheka AO et al. Am J Med 2010;123:646 -651.

ARRIRM Study (n=4,060)

Obesity Paradox in Atrial Fibrillation

Obesity and CV DiseasesSummary and Conclusions

• Overwhelming evidence supports the importance of obesity in the pathogenesis and progression of most CV diseases

• An Obesity Paradox exists• At present, evidence supports purposeful

weight reduction, especially when combined with increased PA/ET and CRF

• If the current obesity epidemic continues, we may soon witness and unfortunate end to the steady increase in life expectancy

Lavie CJ et al. JACC 2009;53:1925-1932

Page 15: Fri Lavie 825 - Baptist Health South FloridaLavie CJ et al. Nat.Rev.Endocrinol 2015;11:55-62 (published online Sept 30,2014) Obesity and Atrial Fibrillation • As with obesity, AF

2/11/2017

15

Weighing the “Heavy” Cardiovascular Burden of Obesity

and the “Obesity Paradox”

Carl J. Lavie, MD, FACC, FACP, FCCP

Professor of Medicine

Medical Director, Cardiac Rehabilitation and

Preventive Cardiology

Director, Exercise Laboratories

John Ochsner Heart and Vascular Institute

Ochsner Clinical School-The UQ School of Medicine

New Orleans, La

Carl J. Lavie, MD, FACC, FACP, FCCP

Professor of Medicine

Medical Director, Cardiac Rehabilitation and

Preventive Cardiology

Director, Exercise Laboratories

John Ochsner Heart and Vascular Institute

Ochsner Clinical School-The UQ School of Medicine

New Orleans, La